CVE:VPTVentriPoint Diagnostics Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding VentriPoint Diagnostics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$0.08 0.00 (0.00 %) (As of 05/29/2020 04:00 PM ET) Add Compare Share Today's RangeC$0.08Now: C$0.08▼C$0.0850-Day RangeC$0.08MA: C$0.08▼C$0.1052-Week RangeC$0.07Now: C$0.08▼C$0.20VolumeN/AAverage Volume182,396 shsMarket CapitalizationC$5.58 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlinesSocial Media Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease primarily in Canada, the Unites States, and China. The company offers Ventripoint Medical System, medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides a suite of applications for various heart diseases and imaging modalities, including congenital heart diseases, left or right heart failure, and normal hearts. The company was incorporated in 2005 and is headquartered in Toronto, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for VentriPoint Diagnostics. Previous Next 2.9 Community Rank Outperform VotesVentriPoint Diagnostics has received 19 “outperform” votes. (Add your “outperform” vote.)Underperform VotesVentriPoint Diagnostics has received 14 “underperform” votes. (Add your “underperform” vote.)Community SentimentVentriPoint Diagnostics has received 57.58% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about VentriPoint Diagnostics and other stocks. Vote “Outperform” if you believe VPT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VPT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldVentriPoint Diagnostics does not currently pay a dividend.Dividend GrowthVentriPoint Diagnostics does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, VentriPoint Diagnostics insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of VentriPoint Diagnostics is -1.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of VentriPoint Diagnostics is -1.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.58 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolCVE:VPT Previous Symbol CUSIPN/A CIKN/A Webwww.ventripoint.com Phone416-848-4156Debt Debt-to-Equity RatioN/A Current Ratio0.09 Quick Ratio0.04Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$81,023.00 Price / Sales68.85 Cash FlowC$0.00 per share Price / Cash Flow42.50 Book ValueC($0.04) per share Price / Book-2.22Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares69,725,904Market CapC$5.58 million Next Earnings DateN/A OptionableNot Optionable TSXV:VPT Rates by TradingView Receive VPT News and Ratings via Email Sign-up to receive the latest news and ratings for VPT and its competitors with MarketBeat's FREE daily newsletter. VentriPoint Diagnostics (CVE:VPT) Frequently Asked Questions Has VentriPoint Diagnostics been receiving favorable news coverage? Media stories about VPT stock have been trending somewhat positive recently, according to InfoTrie. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. VentriPoint Diagnostics earned a coverage optimism score of 1.2 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutVentriPoint Diagnostics. Who are some of VentriPoint Diagnostics' key competitors? Some companies that are related to VentriPoint Diagnostics include Deepmatter Group (DMTR), Imagion Biosys (IBX), LED Medical Diagnostics (LMD), Cambridge Cognition (COG), Dorsavi (DVL), Smiles Inclusive (SIL), Imaging Dynamics (IDL), Lifespot Health (LSH), Cryosite (CTE), 3D Signatures (DXD), Med Biogene (MBI), BioMark Diagnostics (BUX), Carl Data Solutions (CRL), EPIGENOMICS AG/S (EPGNY) and Eternity Healthcare (ETAH). View all competitors. What other stocks do shareholders of VentriPoint Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some companies that other VentriPoint Diagnostics investors own include Resverlogix (RVX), Kootenay Silver (KTN), ProMetic Life Sciences (PLI), Barkerville Gold Mines (BGM), Bird Construction (BDT), Bombardier, Inc. Class B (BBD.B), AuRico Gold (AUQ), Antibe Therapeutics (ATE), Aequus Pharmaceuticals (AQS) and Aptose Biosciences (APTO). Who are VentriPoint Diagnostics' key executives? VentriPoint Diagnostics' management team includes the following people: Dr. George Adams, CEO & Director (Age 68)Mr. Desmond Hirson, PresMs. Ellen Briant, CFO & Corp. Sec.Dr. Alvira Macanovic Ph.D., VP of Devel. & OperationsMs. Jessica Naman, Marketing Mang. What is VentriPoint Diagnostics' stock symbol? VentriPoint Diagnostics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VPT." How do I buy shares of VentriPoint Diagnostics? Shares of VPT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is VentriPoint Diagnostics' stock price today? One share of VPT stock can currently be purchased for approximately C$0.08. How big of a company is VentriPoint Diagnostics? VentriPoint Diagnostics has a market capitalization of C$5.58 million and generates C$81,023.00 in revenue each year. What is VentriPoint Diagnostics' official website? The official website for VentriPoint Diagnostics is www.ventripoint.com. How can I contact VentriPoint Diagnostics? The company can be reached via phone at 416-848-4156. This page was last updated on 5/31/2020 by MarketBeat.com Staff
